MYC and neoplasm: Tumor cells with constitutively elevated Myc escape from apoptosis in the context of loss of control mechanisms (e.g., p14ARF or p53 mutation, MDM2 overexpression), along with the gain of pro-survival signals (e.g., Bcl-2 and NF-κB activation).